CD8A and myeloid sarcoma: In MS, the frequency of CD8+ T cells specific for EBV lytic and latent antigens is higher in active and inactive MS patients, respectively, compared to healthy donors, underlying the importance of the activation of the anti-EBV response in MS [39].